PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 53 filers reported holding PROQR THRAPEUTICS N V in Q2 2023. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opus Point Partners Management, LLC | 307,692 | $992,000 | 0.86% |
| DAFNA Capital Management LLC | 230,770 | $744,000 | 0.40% |
| Redmile Group, LLC | 1,558,392 | $5,026,000 | 0.22% |
| SPHERA FUNDS MANAGEMENT LTD. | 530,000 | $1,709,000 | 0.20% |
| SABBY MANAGEMENT, LLC | 347,245 | $1,120,000 | 0.10% |
| Artal Group S.A. | 1,900,000 | $6,128,000 | 0.09% |
| Genovese Burford & Brothers Wealth & Retirement Plan Management, LLC | 7,500 | $24,000 | 0.06% |
| Orbimed Advisors | 1,302,955 | $4,202,000 | 0.05% |
| ALTRINSIC GLOBAL ADVISORS LLC | 191,360 | $617,000 | 0.02% |
| JENNISON ASSOCIATES LLC | 2,635,552 | $8,500,000 | 0.01% |